What does CUSIP 05360L403 represent in this 13F holders report?

CUSIP 05360L403 is the security identifier for ATXI - AVENUE THERAPEUTICS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held ATXI - AVENUE THERAPEUTICS, INC. - Common Stock in Q2 2024?

8 institutional investors reported ATXI - AVENUE THERAPEUTICS, INC. - Common Stock for Q2 2024. Use the holders table for investor-level position and value details.

AVENUE THERAPEUTICS, INC. - Common Stock (ATXI)

CUSIP: 05360L403

Q2 2024 13F Holders as of 30 Jun 2024

Security type / class: Equity / Common Stock
Total 13F shares: 116,349
Total 13F value: $407,223
Share change: +116,349
SEC-reported price per share: $3.50
Number of holders: 8
Value change: +$407,223
Number of buys: 8
Shares outstanding: 3,190,732

Security key

05360L403

Report period

Q2 2024

Institutions

Top holders

ATXI full security history Ownership snapshot Full 13F holder table AVENUE THERAPEUTICS, INC. SEC filings AVENUE THERAPEUTICS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of ATXI - AVENUE THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Robert L. Davidow

Disclosed value leader

Robert L. Davidow

Comparable rows

0/15

Latest evidence

31 Mar 2024

3/4/5 13F Highest disclosed value: $170,772 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Robert L. Davidow has the largest disclosed position value at $170.8K.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Robert L. Davidow's linked filing trail.

Disclosed position value Top 5

Robert L. Davidow $170.8K

Lucy Lu $104.9K

SABBY MANAGEMENT, LLC $99K

TWO SIGMA SECURITIES, LLC $26.3K

Joseph Walter Vazzano $23.2K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Robert L. Davidow	3/4/5 10%+ Owner 3/4/5	— class O/S missing	$170,772 1,219,800 shares	—	11 Dec 2023
Lucy Lu	3/4/5 President, CEO, Director 3/4/5	— class O/S missing	$104,853 748,949 shares	—	17 Dec 2021
SABBY MANAGEMENT, LLC	13F Company 13F	— class O/S missing	$98,962 670,926 shares	—	31 Mar 2024
TWO SIGMA SECURITIES, LLC	13F Company 13F	— class O/S missing	$26,259 178,025 shares	—	31 Mar 2024
Joseph Walter Vazzano	3/4/5 Chief Financial Officer 3/4/5	— class O/S missing	$23,206 165,757 shares	—	17 Dec 2021
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F Company 13F	— class O/S missing	$10,612 71,947 shares	—	31 Mar 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

116,349

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders

Q2 2024 holders

Holder diff

Investor	Q1 2024 Shares	Q2 2024 Shares	Share Diff	Share Chg %	Q1 2024 value	Q2 2024 value	Value change	Value Chg %